86.22.Z - Specialist medical practice
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
26 - Manufacture of computers, electronic and optical products
47 - Retail trade
72 - Scientific research and development activities
74 - Other professional, scientific and technical activities
77 - Rental and leasing
86.21.Z - General medical practice
86.9 - Other healthcare activities
2019 | 2020 | ||
---|---|---|---|
K PLN | K PLN | % | |
Gross profit (loss) | -0,1 | -0 | 60,8 |
EBITDA | -0,1 | -0 | 60,8 |
Short time liabilities | 1,3 | 1,5 | 9,8 |
Equity capital | 4,8 | 4,3 | -9 |
Operating profit (EBIT) | -0,1 | -0 | 60,8 |
Assets | 6,1 | 5,8 | -4,9 |
Net profit (loss) | -0,2 | -0,4 | -92,1 |
Cash | 5,1 | 4,8 | -5,9 |
Net income from sale | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 1,3 | 1,5 | 9,8 |
Working assets | 5,1 | 4,8 | -5,9 |
Depreciation | 0 | 0 | 0 |
% | % | p.p. | |
Profitability of capital | -4,7 | -9,9 | -5,2 |
Equity capital to total assets | 78,2 | 74,8 | -3,4 |
Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 3.816208600997925 | 3.27012300491333 | -0,5 |
Net dept to EBITDA | 55.36640930175781 | 132.8941650390625 | 77,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane